“Abingdon Health and its subsidiaries CS Lifesciences, IVDeology and Abingdon Analytical work with founders across a range of IVD (in vitro diagnostics) and MedTech sectors. Many of our partners are working through the fundraising process and we always try to support founders and CEOs in aligning their development strategy with their fundraising strategy. Often we are also asked to discuss the development plans with funders as they conduct due diligence on possible investment and gain confidence on the timing of milestones, the management of risk and the path to market. As a former investment banker advising healthcare companies on fundraisings and now a CDMO (contract development and manufacturing organisation) partner to IVD and MedTech companies, I have seen both aspects of this and I understand the challenges in synchronising development, regulatory progress, and fundraising. I’m also delighted that Jonny Sharp, co-founder of corporate advisory group Cerelo has added his insights and perspectives to this article, given his extensive experience of working with VC (venture capitalists) and other finance providers.”
Insights
Aligning IVD Development, Regulation & Fundraising from Day One
Let's talk
Whether you’re a technology or media business, looking for M&A advice or raising capital – drop us a line.